U.S. IPO Weekly Recap: Diabetes Medtech MiniMed Slides 8% In A Quiet Week For IPOs

Renaissance Capital IPO Research7.42K FollowersFollow5ShareSavePlay(4min)CommentsSummaryThe March IPO market started off with a quiet week.MiniMed Group completed the week’s sole IPO, joined by two SPACs, and just one small issuer joined the pipeline.One large IPO and one direct listing are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week.Street research is expected for five companies in the week ahead, and ten lock-up periods will be expiring. DariaRen/iStock via Getty Images The March IPO market started off with a quiet week. MiniMed Group (MMED) completed the week’s sole IPO, joined by two SPACs, and just one small issuer joined the pipeline. Medtronic carve-out MiniMed priced belowThis article was written byRenaissance Capital IPO Research7.42K FollowersFollowRenaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance International IPO ETF (NYSE: IPOS). Individual investors can get a free overview of the IPO market on www.renaissancecapital.com, and try a free trial of our premium platform, IPO Pro (ipopro.renaissancecapital.com).

Through Renaissance Capital’s pre-IPO research service, institutional investors get an independent opinion, in-depth fundamental analysis, and customizable financial models on all IPOs.